Zum Inhalt

memo - Magazine of European Medical Oncology

Ausgabe 2/2025

Inhalt (16 Artikel)

Best of ESMO 2024: gynecologic cancers

  • Open Access
  • short review

Stephan Polterauer

ESMO 2024: highlights in breast cancer

  • Open Access
  • short review

Simon Udovica, Muna Ferner, Maximilian Marhold, Kathrin Strasser-Weippl, Rupert Bartsch

ESMO 2024

  • editorial

Rupert Bartsch, Wolfgang Hilbe

Best of ESMO: pan-tumor highlights

  • Open Access
  • short review

Thorsten Füreder

Cure for multiple myeloma?

  • Open Access
  • review

Klaus Podar

Current and future pharmacological therapies for extensive-stage small-cell lung cancer

  • Open Access
  • short review

Johannes Schöche, Ariane Steindl, Thorsten Fuereder, Barbara Kiesewetter

Novel mutated Dubin–Johnson syndrome diagnosed during acute promyelocytic leukemia treatment

  • original report

Hacer Berna Afacan Öztürk, Murat Albayrak, Merih Reis Aras, Fatma Yılmaz, Neslihan Düzkale

CRLF2 expression associated with poor outcome in Philadelphia-negative acute lymphoblastic leukemia

  • original report

Amal M. El-Afifi, Nermeen A. Nabih, Abdelallah A. El Komy, Yasser H. Elnahass, Haydi S. Mohamed

BACE (Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) conditioning regime for patients with lymphoma undergoing autologous stem cell transplant

  • original report

Joydeep Chakrabartty, Arijit Bishnu, Akash Bhojgaria, Sara Panmei, Mihir Das, Keisam Sanjita Devi

Evaluating antifungal prophylaxis strategies in pediatric acute myeloid leukemia: a retrospective, single-center analysis of amphotericin B, itraconazole, and voriconazole

  • Open Access
  • original report

Anna Cvrtak, Heidrun Boztug, Nora Mühlegger, Andishe Attarbaschi, Gernot Engstler, Waltraud Friesenbichler, Michael N. Dworzak